Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • News

    Myocarditis rare, macrophage infiltration common at COVID autopsy

    November 18, 2020

    An autopsy study shows myocarditis is uncommon, seen in only 14% of COVID-19 deaths, but macrophage infiltration is very common and might explain cardiac imaging findings from earlier studies.

  • News

    Cardiac arrest in COVID-19 pandemic: ‘Survival is possible’

    November 17, 2020

    Results of new studies of in- and out-of-hospital cardiac arrest underline that, despite lower survival rates during the pandemic, rates are “not zero,” and response is “not futile.”

  • 1
    News

    New-onset AFib common but unrecognized in the month after cardiac surgery

    November 17, 2020

    Results of SEARCH-AF trial show one in five cardiac surgery patients with no history of atrial fibrillation develop it within 30 days post discharge.

  • 1
    News

    Empagliflozin favorably reshaped left ventricles in HFrEF patients

    November 15, 2020

    Results from two separate randomized studies showed empagliflozin treatment of patients with HFrEF produced significant heart remodeling.

  • 1
    News

    Intravenous iron reduces HF readmissions: AFFIRM-AHF

    November 14, 2020

    The results are likely to change heart failure guidelines, which currently give a lukewarm recommendation for intravenous iron in the US, experts say.

  • 1
    News

    GALACTIC-HF: New ‘myotropic’ drug class shows modest HFrEF benefit

    November 13, 2020

    Omecamtiv mecarbil safely met its primary efficacy endpoint in patients with heart failure with reduced ejection fraction in GALACTIC-HF, but with a modest effect.

  • News

    New reports guide return to play in athletes with COVID-19

    November 13, 2020

    Researchers found a high prevalence of pericardial involvement in college-student athletes who have recovered from COVID-19.

  • 1
    News

    No link shown between thyroid dysfunction and heart failure

    November 10, 2020

    Analysis of nearly 5,000 English heart failure patients showed no significant link between thyroid dysfunction and survival.

  • 1
    News

    Higher cardiovascular risks in Kawasaki disease persist 10-plus years

    November 8, 2020

    Researchers evaluated the incidence of myocardial infarction, stroke, death, and more in a follow-up study of Kawasaki disease survivors, compared to unaffected children.

  • News

    First-of-its kind guideline on lipid monitoring in endocrine diseases

    November 6, 2020

    A new guideline from the Endocrine Society calls for heightened awareness of cholesterol management and treatment in endocrine diseases beyond diabetes; the aim is to make lipid panel routine in assessment.

Previous1 … 21 22 23 24 25 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences